参考文献/References:
[1] Ciccarelli A, Daly AF, Beckers A. The epidemiology of
prolactinomas [J]. Pituitary, 2005, 8(1): 3-6.
[2] Knosp E, Steiner E, Kitz K. Pituitary adenomas with inva-
sion of the cavernous sinus space: a magnetic resonance
imagi ng classification compared with surgical findings [J].
Neurosurgery, 1993, 33(4): 610-618.
[3] Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and
treatment of hyperprolactinemia: an Endocrine Society
clinical practice guideline [J]. J Clin Endocrinol Metab,
2011, 96(2): 273-288.
[4] 中国垂体腺瘤协作组. 中国垂体催乳素腺瘤诊治共识
（2014版）[J]. 中华医学杂志，2014，（31）： 2406-2411.
[5] Webster J, Piscitelli G, Polli A, et al. A comparison of
cabergoline and bromocriptine in the treatment of hyper-
prolactinemic amenorrhea Cabergoline Comparative Study
Group [J]. N Engl J Med, 1994, 331(14): 904-909.
[6] Ono M, Miki N, Kawamata T, et al. Prospective study of
high-dose cabergoline treatment of prolactinomas in 150
patients [J]. J Clin Endocrinol Metab, 2008, 93(12): 4721-
4727.
[7] Kreutzer J, Buslei R, Wallaschofski H, et al. Operative
treatment of prolactinomas: indications and results in a cur-
rent consecutive series of 212 patients [J]. Eur J Endocri-
nol, 2008, 158(1): 11-18.
[8] Babey M, Sahli R, Vajtai I, et al. Pituitary surgery for small
prolactinomas as an alternative to treatment with dopamine
agonists [J]. Pituitary, 2011, 14(3): 222-230.
[9] Losa M, Mortini P, Barzaghi R, et al. Surgical treatment of
prolactin-secreting pituitary adenomas: early results and
long-term outcome [J]. J Clin Endocrinol Metab, 2002, 87
(7): 3180-3186.
[10] 陈 娟，淦 超，李朝曦，等. 假性包膜在垂体催乳素微腺
瘤经蝶窦手术中的意义[J]. 中华神经外科杂志，2014，30
（10）：1016-1018.
相似文献/References:
[1]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[2]王国良 高 寒 张小鹏 公方和 李天栋.89例垂体腺瘤的手术治疗体会[J].中国临床神经外科杂志,2016,(07):435.[doi:10.13798/j.issn.1009-153X.2016.07.016]
[3]王亚平 贾晓雄 王 珺 王林林 谭溢涛 马德得 夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(06):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[4]张海红 马 磊 张 威 郭 康 衡立君 贾 栋.垂体腺瘤MRI特征与视觉功能损害的关系分析[J].中国临床神经外科杂志,2016,(01):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
ZHANG Hai-hong,MA Lei,ZHANG Wei,et al.Analysis of MRI characteristics and visual function in patient with pituitary adenomas[J].,2016,(06):27.[doi:10.13798/j.issn.1009-153X.2016.01.010]
[5]王先祥 张义泉 李庆新 王 斌 肖 瑾 张 科.经单鼻孔蝶窦入路神经内镜下切除垂体腺瘤[J].中国临床神经外科杂志,2015,(12):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
WANG Xian-xiang,ZHANG Yi-quan,LI Qing-xin,et al.Endoscopic endonasal transsphenoidal surgery for pituitary adenomas[J].,2015,(06):715.[doi:10.13798/j.issn.1009-153X.2015.12.004]
[6]马 涛 徐 韬.经蝶入路内镜手术与显微手术治疗垂体腺瘤疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):748.[doi:10.13798/j.issn.1009-153X.2015.12.015]
[7]雷 霆.注重基础训练和知识更新，不断提高垂体腺瘤诊疗水平[J].中国临床神经外科杂志,2015,(10):577.[doi:10.13798/j.issn.1009-153X.2015.10.001]
[8]闫 进 李 松 杨 辉.1H-MRS对卵泡刺激素免疫阳性垂体腺瘤的诊断和预后评估的价值[J].中国临床神经外科杂志,2015,(10):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
YAN Jin,LI Song,YANG Hui..Value of 1H-MRS to diagnosis and assessment of prognoses in patients with non-functioning gonadotroph adenomas[J].,2015,(06):588.[doi:10.13798/j.issn.1009-153X.2015.10.004]
[9]夏为民 邵耐远 唐 科.神经内镜辅助经鼻蝶入路手术治疗急性垂体腺瘤卒中[J].中国临床神经外科杂志,2015,(07):437.[doi:10.13798/j.issn.1009-153X.2015.07.020]
[10]王齐齐 陈 俊 王焕明 胡 飞.脊索瘤合并垂体腺瘤1例[J].中国临床神经外科杂志,2015,(07):448.[doi:10.13798/j.issn.1009-153X.2015.07.025]
[11]杨庆哲 胡业帅 崔 刚等.男性巨大垂体泌乳素腺瘤的临床特征及手术治疗[J].中国临床神经外科杂志,2021,26(12):943.[doi:10.13798/j.issn.1009-153X.2021.12.015]